Credits: Unsplash
World Breastfeeding Week (WBW), held in the first week of August every year, is a global campaign supported by the World Health Organisation and UNICEF and many Ministries of Health and civil society partners on the protection, promotion and support of breastfeeding. This initiative was started in 1992 to encourage mothers to breastfeed their children and build a support community for new mothers who face any difficulties in breastfeeding.
Gynaecologist, obstetrician and founder of Baby Soon Fertility and IVF Center, Dr Jyoti Bali with 26 years of experience says, “A reason why some mothers stopped breastfeeding was because of the increased marketing of formula as a convenient solution compared to breastfeeding.”
Experts agree that women undergo physical changes in their bodies during their pregnancy and while breastfeeding too, however, these have been exaggerated. “Breastfeeding can lead to temporary changes in breast size and shape, but these changes are typically normal and revert to baseline after weaning. Perceptions about breastfeeding causing long-term body changes are often unscientific or exaggerated,” says Dr Rao.
These were some of the reasons why women stopped breastfeeding and thus an initiative like World Breastfeeding Week was started. This also aims to highlight the health benefits to the mother and the child on breastfeeding.
Rao says that for the mother, it helps in faster postpartum recovery, reduces the risk of certain cancers, and can help with postpartum weight loss.
“Breast Feeding helps the mothers to shed their pregnancy weight more quickly because the production of milk requires the burning of calories,” agrees Dr Bali.
Other health benefits to mothers are postpartum healing, bonding with the baby and a decrease in the risk of ovarian cancer, mentions Dr Bali.
There are also nutritional values that help a preterm baby in his or her development. “For example, breast milk's higher protein content makes it easier for premature babies to absorb and digest than formula, which encourages better weight gain. Premature babies often have specific nutritional needs due to their early birth. Breast milk provides a tailored balance of proteins, fats, and carbohydrates that support their rapid growth and development. The composition of breast milk adjusts to meet the changing needs of a preterm infant, including higher levels of certain nutrients,” says Dr Goel.
Dr Bali also points out that breast milk contains antibodies, probiotics and DHA and ARA, a kind of fatty acids that are required for brain development. Thus, a baby can benefit a great deal from breastfeeding.
Poor breastfeeding practices in infancy and early childhood, resulting in malnutrition, contribute to impaired cognitive and social development, poor school performance and reduced productivity in later life.
Sarwa points out that psychological factors like stress, anxiety, postpartum depression, poor latch due to anatomical issues or improper positioning, and other medical conditions are the common reasons for this. “Identification and management of the specific cause, appropriate counselling by a healthcare provider, support (emotional and workplace both) and alternative feeding options,” he says.
Do not be worried about its safety, Dr Rao says that donated milk is screened, pasteurised, and distributed to ensure safety and nutrition.
“Purchasing a superior electric breast pump can increase the effectiveness of the procedure. Maintaining a consistent pumping schedule—ideally, every three to four hours—helps keep the milk supply steady. Pumped milk can be refrigerated for up to four days if stored in sterile containers or bags that have been labelled with the date and time. Milk can be frozen and thawed for extended storage,” suggests Dr Goel.
Credit: AI generated image
Many people carry the thalassemia gene without knowing it because they may not have any symptoms. A simple carrier screening test before pregnancy can help couples understand risks and make informed decisions while planning parenthood.
Parenthood planning today is not only about financial preparation or healthy lifestyle changes, but also about understanding genetic health risks that can impact the child’s future. And one such condition that tends to go unnoticed is thalassemia carrier status.
Did you know? Many individuals discover they are carriers only after facing difficulties during pregnancy or after the birth of a child with thalassemia major.
Thalassemia is an inherited blood disorder that affects the production of hemoglobin, the protein in red blood cells that carries oxygen throughout the body. People who are carriers usually live normal and healthy lives and may not experience major symptoms. Because of this, many remain unaware of their carrier status for years.
However, it becomes a matter of concern when both partners are carriers of the thalassemia gene. In such cases, there is a huge risk that the child may inherit thalassemia major, a severe condition that may require lifelong blood transfusions, regular hospital visits, medications, and continuous medical care.
These are some of the challenges faced by families: So, challenges are that the thalassemia carrier status is often detected very late. Mild tiredness or anemia may be ignored or mistaken for iron deficiency, and many will not seek help.
So, couples do not consider genetic testing before marriage or pregnancy because they feel healthy and have no family history of the disease. When a child is born with thalassemia major, families may face stress, anxiety, repeated hospital visits, financial burden, and long-term treatment responsibilities. The condition can also affect the child’s growth, immunity, and overall quality of life.
This is why screening is important for couples: Carrier screening is a simple blood test that helps identify whether a person carries the thalassemia gene. If one partner tests positive, the other partner is advised to get tested as well.
Early screening before pregnancy helps couples understand their risks and explore available options with proper guidance. Thalassemia carrier screening is a small step that can make a major difference in parenthood planning.
Increasing awareness and encouraging timely testing can help families make informed decisions and reduce the burden of severe thalassemia in future generations. So, it is imperative to go for timely screening as advised by the expert and improve the quality of life.
Credit: AI generated image
Preeclampsia is usually discussed as a pregnancy complication, but the risk does not end automatically after childbirth. Delivery is an important part of treatment, but it is not an instant cure. A woman can still develop postpartum preeclampsia in the days or weeks after delivery, even if her blood pressure was normal during pregnancy.
The risk is highest soon after childbirth, but it can remain for up to six weeks. This period needs close attention because the mother is recovering, sleep-deprived, caring for a newborn, and may mistake warning signs for normal post-delivery discomfort. This is when the condition can become dangerous if symptoms are missed.
The warning signs of postpartum preeclampsia should be taken seriously. A severe headache, blurred vision, seeing spots, swelling of the face or hands, pain below the ribs, nausea, vomiting, breathlessness, chest pain, reduced urination, sudden weight gain, or very high blood pressure should be checked urgently.
If postpartum preeclampsia is not treated in time, it can lead to seizures, known as eclampsia, and may also cause stroke, fluid in the lungs, acute liver or kidney injury, and, in rare severe cases, hepatic subcapsular hematoma, which is bleeding beneath the capsule of the liver, or intracranial bleeding, also called brain hemorrhage. In the most severe cases, it can be fatal.
The reassuring part is that the condition is treatable when identified early. Treatment may include blood pressure medicines such as labetalol, nifedipine, or amlodipine, magnesium sulphate if there is a risk of seizures, and diuretics in selected cases where there is fluid overload. Many of these decisions can be safely planned even if the mother is breastfeeding, but treatment should always be guided by her treating doctor.
The responsibility should not fall only on the mother. Families need to watch her health with the same seriousness with which they attend to the newborn. As a precaution, blood pressure checks should continue at home or during scheduled visits, especially in the first few weeks after delivery. Postpartum follow-ups should not be missed, prescribed medicines should be taken properly, and self-medication should be avoided, particularly painkillers or over-the-counter drugs unless approved by the doctor. If symptoms worsen, or if there is headache, breathlessness, chest pain, visual disturbance, or swelling, she should be taken back to the hospital without delay.
A history of preeclampsia also remains important after recovery because it can increase the woman’s future risk of chronic hypertension, heart disease, stroke, and kidney disease. Postpartum care should never be treated as a formality. It is an essential part of protecting the mother’s recovery, her future pregnancies, and her long-term health.
Credit: iStock
Bone marrow transplant (BMT), also known as hematopoietic stem cell transplant, is regarded as a lifesaving and even curative therapy. It is important to note that no surgery is required; rather, stem cells are transfused from a bag, like a blood transfusion.
BMT has revolutionized the treatment of several severe pediatric disorders, including thalassemia major, severe aplastic anemia, immunodeficiency disorders, high-risk blood cancers, and certain neurological and metabolic disorders such as metachromatic leukodystrophy and mucopolysaccharidoses (MPS). Despite major progress in transplant science, many still see BMT as a last resort. This can have a high effect on the survival rate, recovery process, and overall quality of life.
One big reason for postponing transplant decisions is the belief that BMT should only be considered after all standard therapies have failed. There is also limited awareness about the excellent outcomes and curative potential of BMT in many benign pediatric disorders when performed early.
Children often go through repeated chemotherapy cycles, frequent blood transfusions, or long-term supportive care before anyone seriously discusses transplant. While this therapy may help in stabilizing the condition temporarily, it can cause lasting damage to the organs, increase the risk of infections, and affect the immune system, making transplant surgeries risky and less successful.
For instance, in children with thalassemia major, years of blood transfusions can lead to iron overload, which harms the heart and liver, reducing their ability to handle intense transplant conditioning. Likewise, in diseases like MPS, metachromatic leukodystrophy, where the disease has progressed, role of BMT becomes guarded.
In addition to medical hesitation, systemic and emotional barriers also cause delays. The long-standing belief that a fully matched donor is essential has also changed significantly, with recent years witnessing remarkable growth and success in haploidentical (half-matched) donor BMTs. There are challenges related to awareness and affordability in India. The fear of risks such as graft-versus-host disease, infection, or death from transplant surgery results in parents adopting a "wait and see" attitude until their child’s health deteriorates further.
It is ironic that lack of awareness and accessibility to pediatric bone marrow transplant specialists are also among the factors that can cause delay in proper diagnosis and referral. Yet, the wait could put the children’s lives at greater risk due to the damage caused by chemotherapy and other forms of treatment.
Modern medical professionals emphasize that BMT does not have to be used only as a “last resort” treatment but can be administered in a timely manner to provide a cure for the patient.
© 2024 Bennett, Coleman & Company Limited